Form 8-K/A · Current Report · Filed 2024-02-06
GE HealthCare Technologies Announces Fourth Quarter and Fiscal Year 2023 Financial Results
GE HealthCare Technologies Inc. announced its fourth quarter and fiscal year 2023 financial results on February 6, 2024. The unaudited Consolidated and Combined Statements of Income are included as Exhibit 99 in the Current Report on Form 8-K. The press release furnished pursuant to Item 2.02 does not contain specific earnings beats or misses details.
- Filer
- Ge Healthcare Technologies Inc. GEHC · NASDAQ
- Filed
- Accession
- 0001932393-24-000015
- CIK
- 0001932393
- Signal
- Low impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Results of Operations and Financial Condition
Financial Statements and Exhibits
Market reaction
Close before filing
$73.41
Next session
+11.5%
Since filing
-7.3%
Latest close
$68.02
What happened, not what will happen — closing prices around the filing date.
Exhibits (1)
About Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc. is a prominent player in the healthcare industry, focused on providing transformative medical technology and diagnostic solutions. Specializing in imaging, monitoring, and diagnostic equipment, the company plays a crucial role in enhancing clinical outcomes, improving patient care, and driving medical technology innovations. Ge Healthcare Technologies Inc. is recognized for its advancements in medical imaging systems, including MRI, CT, and ultrasound technologies, which aid in early disease detection and treatment planning. In addition to its hardware innovations, the company is actively involved in digital healthcare solutions, employing data analytics and AI to support precise diagnoses and personalized medicine. The impact of Ge Healthcare Technologies extends across various healthcare sectors, including hospitals, clinics, and research institutions, underscoring its importance in advancing clinical capabilities and operational efficiencies within the healthcare system. Ge Healthcare Technologies Inc. maintains a strategic presence in global markets, bolstering healthcare infrastructure and supporting public health initiatives. By continuously striving to innovate and improve healthcare delivery, it remains a significant entity within the broader medical technology and life sciences industry, contributing to the future of healthcare.
Never miss another GEHC filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.